| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Siemers Eric is a Chief Medical Officer at ABOS. Recent filings cover 0 purchases and 5 sales. Those positions are worth an estimated $639K at current prices.
Our model assigns Siemers Eric a below-average insider score of 49/100, based on 5 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of +12.6%.
Siemers Eric's largest disclosed position is in ABOS as Chief Medical Officer, worth about $639K. The recent filings there lean toward selling, a net 28,036 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 10,834 | $1.96 | $21,277.28 | -3.2% | +40.8% | - | |
| Jan 21, 2025 | ABOS Acumen Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 3,219 | $1.59 | $5,118.21 | -1.9% | -35.0% | +11.0% | |
| Jan 3, 2025 | ABOS Acumen Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 10,859 | $1.85 | $20,046.80 | -9.2% | -48.0% | +6.3% | |
| Jan 18, 2024 | ABOS Acumen Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 3,124 | $3.71 | $11,603.79 | -2.6% | -5.7% | -55.2% |